[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filing a Form 144 discloses a proposed sale of 92,247 common shares through Fidelity Brokerage Services with an aggregate market value of $2,953,432.60, and an approximate sale date of 08/27/2025. The filing reports total shares outstanding of 59,504,269. The shares to be sold were acquired via stock options granted on 01/31/2018 (21,870 shares) and 03/27/2019 (70,377 shares), with cash payment indicated at sale. The filer also reported a prior sale on 07/17/2025 of 3,171 shares for $85,254.87. The notice includes the required representation that the seller does not possess undisclosed material adverse information.

Positive

• Clear disclosure of the number of shares (92,247), aggregate market value ($2,953,432.60), broker, and approximate sale date
• Acquisition history provided showing the shares were from option grants dated 01/31/2018 and 03/27/2019
• Includes prior sale detail: 3,171 shares sold on 07/17/2025 for $85,254.87, supporting transaction transparency
• Compliance representation that the seller does not possess undisclosed material adverse information

Negative

• Planned sale size disclosed (92,247 shares) which will increase public float if executed
• No contextual financial or operational information about the issuer is provided in this filing

Insights

Securities Analyst

TL;DR Routine insider notice of stock sale; provides clear quantities, acquisition dates, and broker details with limited immediate market impact.

The Form 144 is a standard regulatory notice showing an insider intends to sell 92,247 shares acquired under stock option grants from 2018 and 2019. The filing supplies execution logistics including broker, aggregate value, and an approximate sale date. Given the disclosure of acquisition sources and a recent small sale on 07/17/2025, this document primarily notifies the market and satisfies Rule 144 reporting requirements rather than signaling a material corporate event.

Corporate Governance Expert

TL;DR Compliance-focused disclosure consistent with insider sale rules; confirms representation about absence of undisclosed material information.

The filing documents the provenance of the shares (option grants) and includes the statutory attestation about non-possession of material non-public information. It also lists the broker and sale mechanics, which supports transparency and regulatory compliance. This form does not provide operational or financial performance details and should be read solely as an insider-sale notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	92247	2953432.60	59504269	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/27/2025	Options Granted - 01/31/2018	Issuer			21870	08/27/2025	Cash
Common	08/27/2025	Options Granted - 03/27/2019	Issuer			70377	08/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Chaim Indig 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	3171	85254.87

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 92,247 common shares through Fidelity with an aggregate market value of $2,953,432.60 and an approximate sale date of 08/27/2025.

How were the Phreesia (PHR) shares being sold acquired?

The shares were acquired via stock option grants: 21,870 shares from options granted 01/31/2018 and 70,377 shares from options granted 03/27/2019.

Has the filer sold any Phreesia (PHR) shares recently?

Yes. The filing reports a prior sale of 3,171 shares on 07/17/2025 for $85,254.87.

Who is the broker handling the proposed Phreesia (PHR) sale?

The broker named is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI.

Does the Form 144 include a statement about material non-public information?

Yes. The filer represents by signing the notice that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.